Biocept, Inc. (BIOC)
(Delayed Data from NSDQ)
$0.91 USD
+0.01 (1.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $0.91 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Biocept, Inc. [BIOC]
Reports for Purchase
Showing records 21 - 40 ( 65 total )
Company: Biocept, Inc.
Industry: Medical Services
Company: Biocept, Inc.
Industry: Medical Services
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Biocept, Inc.
Industry: Medical Services
Termination of Coverage
Provider: H.C. Wainwright & Co., Inc.
Company: Biocept, Inc.
Industry: Medical Services
Termination of Coverage
Provider: Rodman & Renshaw, Co.
Company: Biocept, Inc.
Industry: Medical Services
3Q16 Financial Results; Reiterate Buy and Adjusting Price Target to $2.25
Provider: H.C. Wainwright & Co., Inc.
Company: Biocept, Inc.
Industry: Medical Services
Q3 ahead on revenue, balance sheet improved, upgrade to BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Biocept, Inc.
Industry: Medical Services
3Q16 Financial Results; Reiterate Buy and Adjusting Price Target to $2.25
Provider: Rodman & Renshaw, Co.
Company: Biocept, Inc.
Industry: Medical Services
Strong 3Q Highlighted by Record Revenues, Volumes; Catalysts Upcoming
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Biocept, Inc.
Industry: Medical Services
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Biocept, Inc.
Industry: Medical Services
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Biocept, Inc.
Industry: Medical Services
Financing Addresses Overhang;Catalysts Upcoming
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Biocept, Inc.
Industry: Medical Services
Liquid Biopsy Tests Now Available in Canada; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Biocept, Inc.
Industry: Medical Services
Liquid Biopsy Tests Now Available in Canada; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Biocept, Inc.
Industry: Medical Services
Significant Test Volume Growth and Billing - Collection Improvement in 2Q16; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Biocept, Inc.
Industry: Medical Services
Q2 ahead of expectations, but additional dilution coming, lowering rating to HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Biocept, Inc.
Industry: Medical Services
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Biocept, Inc.
Industry: Medical Services
2Q Exceeds Expectations on Continued Strong Volume Growth
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Biocept, Inc.
Industry: Medical Services
Significant Test Volume Growth and Billing - Collection Improvement in 2Q16; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Biocept, Inc.
Industry: Medical Services
Emerging Leader in Liquid Biopsy -Initiating Coverage with a Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Biocept, Inc.
Industry: Medical Services
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.